Amblyopia Clinical Trials

28 recruiting

Amblyopia Trials at a Glance

25 actively recruiting trials for amblyopia are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 17 trials, with the heaviest enrollment activity in Dallas, New York, and Chicago. Lead sponsors running amblyopia studies include Retina Foundation of the Southwest, Jaeb Center for Health Research, and Eyesight Electronics.

Browse amblyopia trials by phase

Treatments under study

About Amblyopia Clinical Trials

Looking for clinical trials for Amblyopia? There are currently 28 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Amblyopia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Amblyopia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 25 trials

Recruiting
Not Applicable

Video Treatment for Amblyopia

Amblyopia
Retina Foundation of the Southwest44 enrolled1 locationNCT05439200
Recruiting
Not Applicable

Optical Correction and Visual Functions of Adults With Amblyopia

Amblyopia
Centre for Eye and Vision Research36 enrolled2 locationsNCT05394987
Recruiting

Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy

StrabismusAmblyopia
The Cleveland Clinic150 enrolled1 locationNCT04310241
Recruiting
Not Applicable

Binocular Amblyopia Treatment

Amblyopia
Retina Foundation of the Southwest120 enrolled1 locationNCT03288948
Recruiting

Ocular Characteristics in Patients With Craniosynostosis

StrabismusIntracranial HypertensionCraniosynostosis+1 more
Centre Hospitalier Universitaire, Amiens65 enrolled1 locationNCT06928727
Recruiting
Not Applicable

Possible Beneficial Effects Of Combined Fluoxetine And Occlusion Therapy In Improving And Maintaining Vision In Amblyopia Using Optical Coherence Tomography Angiography (OCTA) And Visual Evoked Potential (VEP). The Aim Of The Study Is To Evaluate Possible Beneficial Effects For Different Age Groups.

AmblyopiaVEP
Minia University50 enrolled1 locationNCT07417046
Recruiting
Phase 3

Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age

Amblyopia
Jaeb Center for Health Research252 enrolled58 locationsNCT06524882
Recruiting
Phase 3

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

Amblyopia
Jaeb Center for Health Research238 enrolled73 locationsNCT06380517
Recruiting
Phase 3

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

Amblyopia
Jaeb Center for Health Research544 enrolled68 locationsNCT04378790
Recruiting
Not Applicable

Evaluation of AmblyoFix for the Treatment of Unilateral Amblyopia in Children

Amblyopia
Eyesight Electronics33 enrolled1 locationNCT07323953
Recruiting
Not Applicable

Patch-free Occlusion Therapy

Amblyopia
Retina Foundation of the Southwest68 enrolled1 locationNCT05440448
Recruiting
Not Applicable

Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games

Amblyopia
Nova Southeastern University180 enrolled1 locationNCT05522972
Recruiting
Not Applicable

Amblyopia Treatment for Children Aged 8 to 12 Years

Amblyopia
Retina Foundation of the Southwest30 enrolled1 locationNCT07281742
Recruiting
Not Applicable

Evaluation of AmblyoFix for the Treatment of Unilateral Amblyopia

Amblyopia
Eyesight Electronics86 enrolled1 locationNCT07240311
Recruiting

Clinical Data Registry of Amblyopia Patients on Luminopia Treatment

Amblyopia
Luminopia500 enrolled13 locationsNCT06429280
Recruiting
Not Applicable

Novel Amblyopia Treatment With Virtual Reality Games

Amblyopia
Marjean Kulp8 enrolled1 locationNCT06049459
Recruiting
Not Applicable

Effect of Transcranial Magnetic Stimulation on Visual Functions of Adult Amblyopia: a Preliminary Study

Amblyopia
National Taiwan University Hospital30 enrolled1 locationNCT05393739
Recruiting
Not Applicable

AR Training Versus Patching in Unilateral Amblyopia

Amblyopia Unilateral
Eye & ENT Hospital of Fudan University114 enrolled1 locationNCT06498206
Recruiting
Not Applicable

Clinical Treatment of Transcranial Direct Current Stimulation in Older Adolescents With Amblyopia

Amblyopia
Tianjin Eye Hospital40 enrolled1 locationNCT06760910
Recruiting
Not Applicable

Noninvasive Brain Stimulation in Adult Amblyopia

Amblyopia
Midwestern University60 enrolled1 locationNCT06712849